Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

352 results about "Body fluid sample" patented technology

Method for detecting indole, indole-producing bacteria or indole-producing chemicals

In an example method of detecting indole, indole-producing bacteria, or indole-producing chemicals, a polymeric detection tool is exposed to a sample and a red change of the polymeric detection tool is monitored. The polymer detection tool includes an acidic and oxygen soluble polymer and a nitrosation agent impregnated in a wall of the acidic and oxygen soluble polymer. The example method can be used to detect indole-producing bacteria in a body fluid sample.
Owner:THE RGT UNIV OF MICHIGAN +1

Microfluidic devices

A microfluidic device is configured to sample, meter and collect a metered volume of body fluid for analysis by means of capillary transport. The device comprises: an inlet section, for receiving the body fluid sample, the inlet section comprising an inlet port; a metering section configured to receive body fluid from the inlet section and comprising a metering channel, wherein the metering section is arranged to separate a metered volume of body fluid filled in the metering channel; and an outlet section comprising a cavity between an outlet part of the metering channel and an outlet orifice of the device, a hydrophilic porous bridge element conformable to a shape of the cavity and inserted in the cavity to substantially fill the cavity and the outlet orifice, and a capillary means attached to the outlet section in contact with the hydrophilic porous bridge element.
Owner:CAPITAINER AB

Contoured sample path for fluid analyzer

A sensor assembly for analysis of physical parameters and chemical constituents of small volume samples of bodily fluids. Disclosed herein is a sensor panel with an upper surface and a lower surface and at least one analyte sensor located on the lower surface. The sensor assembly also includes an optional adhesive layer and a contoured fluid pathway cutout. The upper surface of the adhesive layer is secured to the lower surface of the sensor panel. The sensor assembly also includes a sensor cartridge base with a fluid inlet and outlet and a contoured fluid pathway extending between the inlet and the outlet. The contoured fluid pathway mirrors the shape and span of the contoured fluid pathway cutout of the adhesive layer. As a fluid sample is input at the fluid inlet, the fluid traverses along the fluid pathway in contact with the at least one analyte sensor.
Owner:SIEMENS HEALTHCARE DIAGNOSTICS INC

Composite amplification detection system for identifying human skin based on microbial markers

The invention relates to a composite amplification detection system for identifying human skin based on microbial markers. The multiplex amplification detection system comprises a primer combination for specifically amplifying five human skin microorganism markers, wherein the human skin microorganism markers are staphylococcus epidermidis, staphylococcus hominis, staphylococcus capitis, staphylococcus aureus and propionibacterium acnes respectively. The invention also provides a kit containing the composite amplification detection system. The multiplex amplification detection system and the kit have relatively good recognition capability on skin of parts such as forehead, cheeks, hands, chest, navel periphery and groin of a human body. Besides, the method is an effective supplement for an existing body fluid identification method, and can effectively identify various common body fluid samples in forensic cases by flexibly combining with a multiple amplification system for saliva and vaginal secretion established by a previous team, so that the accuracy and reliability of identification results are improved, and case investigation and judicial trial are assisted.
Owner:SOUTHERN MEDICAL UNIVERSITY

Body fluid sample collecting device

ActiveCN222081181UBottlesRemovable lids/coversBody fluid specimenSurgery
The utility model provides a body fluid specimen collecting device. The body fluid specimen collecting device comprises a liquid specimen collecting bottle and a replaceable bottle cap, the bottom of the liquid specimen collecting bottle is a telescopic bottle bottom; the telescopic bottle bottom is of a cone structure. The telescopic bottle bottom is telescopically deformed through external force, so that the bottle bottom is changed into an inverted conical shape from an upright conical shape, and when supernate is poured out through the upper bottle opening, cell precipitates are concentrated at the bottom of the conical body and are not easy to pour out of the body fluid sample collection bottle along with the supernate. Therefore, it can be ensured that the number of collected cells meets experimental requirements. The replaceable bottle cap comprises a sealing bottle cap, a filter screen bottle cap and a collecting funnel bottle cap. The sealing bottle cap facilitates transportation and storage of the liquid collecting bottle; the filter screen bottle cap is convenient for filtering impurities; and the collecting funnel bottle cap is convenient for the patient to directly collect urine. And through the connection with different bottle caps, the multi-aspect requirements of patient body fluid collection, sample transportation, pathological technician operation and the like are met.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL

Capture microsphere, preparation method thereof and high-purity exosome enrichment method

The invention discloses a capture microsphere, which is a compound obtained by coupling a microsphere and an exosome marker antibody, and the average particle size of the microsphere is more than 1 [mu] m. The invention also discloses a high-purity exosome enrichment method, which comprises the following steps: crude extraction: taking a fresh body fluid sample, and carrying out ultracentrifugation to preliminarily remove impurities so as to obtain the exosome subjected to crude extraction; and performing fine purification: adding the capture microspheres into the exosome subjected to crude extraction, performing mixed incubation, performing centrifugation, removing supernatant, and performing resuspension so as to obtain the high-purity exosome. The method is lower in cost and more efficient, the obtained exosome sample is high in purity and clinical application degree, and the method can cover multiple body fluid samples at the same time and has good application prospects.
Owner:HANGZHOU XINGYUAN HUAQING BIOTECHNOLOGY CO LTD

Method, system and kit for evaluating sepsis by using NINJ1 protein as marker

The invention relates to the technical field of molecular diagnosis, and discloses a method, a system and a kit for evaluating sepsis by taking NINJ1 protein as a marker, and the content of the NINJ1 protein in a body fluid sample of a patient is determined by methods such as enzyme-linked immunosorbent assay (ELISA) and the like; the measured NINJ1 level is compared with a normal control value, and if the measured NINJ1 level is obviously increased, the patient has sepsis; the correlation between the NINJ1 level and the score SOFA and APACHE II of a sepsis severity scoring system is analyzed, and the higher the NINJ1 level is, the severity of sepsis is. The method can detect the NINJ1 level, and the NINJ1 level can be used as a biomarker for auxiliary diagnosis of sepsis; the severity of sepsis is evaluated according to the NINJ1 level, and risk stratification is carried out on patients; in combination with SOFA and APACHE II scoring systems, the accuracy of predicting the 28-day case fatality rate of the sepsis patient is improved; the NINJ1 level change is dynamically monitored, and the sepsis disease progress and treatment response are evaluated; the NINJ1 level is combined with other clinical indexes, and an individualized treatment scheme is formulated.
Owner:CENT SOUTH UNIV

Planar apparatus for volumetric body fluid collection and manufacturing method thereof

A planar volumetric device for quantifying and handling a body fluid sample is provided. The device has a planar main body, a body fluid sample flow path, an air pump and an air passage. The planar main body includes a first planar surface and a second planar surface. The body fluid sample flow path is disposed in the main body, and has a body fluid sample inlet, a middle junction and a body fluid sample outlet, wherein the middle junction and the body fluid sample outlet define therebetween a specific path segment, by which it is possible to externally observe to which extent the body fluid sample has filled up with the path segment. The air pump is configured to provide an operating air pressure. The air passage has a first end and a second end, wherein the first and the second ends are connected to the air pump and the middle junction respectively, and the specific path segment has a constant volume.
Owner:TAI SAW TECH

Nanoprobe suitable for in-situ liquid biopsy as well as preparation method and application of nanoprobe

The invention relates to the technical field of biological medicine, in particular to a nanoprobe suitable for in-situ liquid biopsy and a preparation method and application of the nanoprobe. The nanoprobe is composed of an anti-protein adsorption membrane fusion liposome and a CRISPR / Cas fluorescence detection system entrapped in the liposome, has excellent anti-protein adsorption capacity, and can still mediate stable and efficient membrane fusion between the liposome and extracellular vesicles in a circulating body fluid sample with complex components. The detection platform based on the CRISPR / Cas gene editing technology provided by the invention can directly realize rapid, in-situ and accurate quantitative detection and analysis of the target nucleic acid marker in the extracellular vesicles in a circulating body fluid sample in a separation-free and lysis-free manner, so that the detection cost is reduced to a certain extent, and the detection efficiency is improved. And the detection steps are greatly simplified, so that the liquid biopsy is quicker, simpler and more convenient, and the detection accuracy is good.
Owner:SUN YAT SEN UNIV +1

Pancreatic cancer diagnosis assistance method, biomarker for detecting pancreatic cancer, colorectal cancer diagnosis assistance method, and biomarker for detecting colorectal cancer

Provided is a test method capable of accurately determining early pancreatic cancer or colorectal cancer. The method for assisting diagnosis of pancreatic cancer includes detecting and / or quantifying a biomarker in a body fluid sample derived from a subject, and the biomarker is FKBP1B, BID, EREG, STAT5B, UFD1, or the like. The method for assisting diagnosis of colorectal cancer includes detecting and / or quantifying a biomarker in a body fluid sample derived from a subject, and the biomarker is BID, FKBP1B, EREG, MYDGF, TACC3, TBCA, FKBP14, MIF, ARF6, MESD, CIRBP, MANF, ERP29, PDLIM7, DNM1, STAT5B, GRAP2, UFD1, SNCA, PLCB2, SULT1A1, ABHD14B, PRKAR1A, or the like.
Owner:NIPPON MEDICAL SCHOOL FOUND

Method for extracting 17 bisphenol compounds and application

The invention discloses a method for extracting 17 bisphenol compounds and application, and the method comprises the following steps: fully mixing a buffer solution and a body fluid sample, fully extracting with a mixed reagent, and collecting an organic phase to obtain an extract of the 17 bisphenol compounds. According to the method, liquid-liquid extraction which is simple and efficient to operate, low in cost and good in repeatability is adopted as a body fluid sample pretreatment method and is combined with an isotope label method and an ultra-high performance liquid chromatography-tandem mass spectrometry technology, qualitative and quantitative detection and separation of 17 bisphenol compounds in different body fluid samples are achieved, the adding standard recovery rate is 70%-120%, and the detection sensitivity is high. Meanwhile, the method has the advantages of high sensitivity, small quantity of isotope internal standards and small solvent loss, meets actual detection requirements, and has higher simplicity and wider detection limit.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Systems and methods for the detection and quantification of ammonia and ammonium in fluids

A system with an analyzer device in fluid communication with a sample of a bodily fluid is configured to chemically or electrochemically convert at least a portion of ammonium (NH4+) contained within the bodily fluid into ammonia (NH3) and dispel the converted ammonia (NH3) into a gas sensing chamber. An ammonia (NH3) sensor located within the gas sensing chamber in conjunction with a processor can quantify an amount of ammonia (NH3) present in the gas sensing chamber in relation to the total ammonia of the bodily fluid.
Owner:THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA +1

Intelligent evaluation system for endometrial receptivity based on biosensor data processing

This invention relates to the field of intelligent information processing technology and discloses an intelligent assessment system for endometrial receptivity based on biosensor data processing. The system acquires signals of multiple types of biomarkers in bodily fluid samples through multi-channel biosensor detection and performs structured preprocessing and quantitative transformation. Based on this, it establishes object-level associations between biosensor data and multi-source information to construct a unified feature data system. Furthermore, it constructs a weighted heterogeneous assessment graph and introduces a manifold stochastic feature modeling mechanism to generate manifold feature data. The manifold features and original features are jointly input into a shared-parameter cyclic Transformer model. Through cyclic inference and consistency constraints, multi-round feature fusion is achieved, outputting the endometrial receptivity assessment result. This invention improves the multi-source data modeling capability and the stability and consistency of the assessment process.
Owner:THE FIRST HOSPITAL OF LANZHOU UNIV +1

Method and kit for detecting cedar allergen-specific IgE antibodies in body fluid samples

Disclosed are a method for detecting sugi allergen-specific IgE antibodies in a body fluid sample, which can improve the detection value of sugi allergen-specific IgE antibodies, and a kit for use therein. The method comprises the following steps: a removal step for removing non-IgE antibodies such as IgG antibodies from the body fluid sample; a reaction step for contacting the antibody-removed body fluid sample obtained in the removal step with a reaction well on a substrate having a reaction well, thereby forming a complex between the allergen and the allergen-specific IgE antibody; the reaction well comprising a region immobilizing the sugi allergen and regions immobilizing one or more allergens other than the sugi allergen; and a detection step for detecting the complex between the sugi allergen and the sugi allergen-specific IgE antibody obtained in the reaction step.
Owner:TORAY INDUSTRIES INC

Treatment stratification based on STK1

A treatment stratification method comprises determining a level of STK1 material in a body fluid sample from a patient diagnosed with prostate cancer using an antibody, or an antigen-binding fragment thereof, specifically binding to a serum form of human TK1. The method also comprises comparing the level of STK1 material with a threshold level and selecting chemotherapy for the patient if the level of STK1 material is equal to or above the threshold value and selecting an androgen receptor signaling inhibitor (ARSI) therapy for the patient if the level of STK1 material is below the threshold value.
Owner:AROCELL

Integrated saliva collection filter

The invention belongs to the technical field of medical body fluid sample collection, and provides an integrated saliva collection filter which comprises a collection tube, a sponge rod used for collecting saliva is detachably connected in the collection tube through an extrusion part, a filter assembly is arranged at one end of the collection tube, and the liquid inlet end of the filter assembly corresponds to the sponge rod; the flexible liquid storage mechanism comprises a liquid mixing assembly, the liquid mixing assembly is connected with the collecting pipe through a connecting base, a spring microbead one-way valve assembly and a buffer liquid storage assembly are arranged in the connecting base, and the liquid outlet end of the spring microbead one-way valve assembly is communicated with the liquid mixing assembly; the liquid outlet end of the filtering assembly is communicated with the liquid mixing assembly through a spring microbead one-way valve assembly, and an automatic liquid leakage assembly is arranged between the buffer liquid storage assembly and the filtering assembly. Saliva collection, filtration and buffer solution mixing can be completed in one step, and the device is small in size, convenient to store and transport, capable of being integrally discarded after being used, environmentally friendly and efficient.
Owner:CHONGQING TECH & BUSINESS UNIV +1

Assay test device and method

ActiveUS12631632B1Disease diagnosisBiological testingGold nanoshellsBlood lancet
A rapid diagnostic device for detecting multiple biomarkers in bodily fluid samples, particularly useful for disease screening including breast cancer. The device comprises a housing containing at least one test strip with a sample receiving zone, conjugate pad, and multiple test zones. The test strip utilizes specific materials including Cytiva GF / DVA and Ahlstrom 1667 sample pads, an Ahlstrom 6613 conjugate pad with carboxylated 150 nm gold nanoshell conjugates, and a Sartorius CN140 membrane with precisely positioned test and control zones. The device simultaneously detects multiple biomarkers, such as hCG and CA-15-3, using specific antibodies. Features include a built-in safety lancet, integrated buffer system, and compatibility with various sample types. Results are available within ten minutes, with options for quantitative analysis via a dedicated reader or smartphone application. This multi-biomarker approach potentially improves screening accuracy compared to single-marker tests, offering versatility for detecting various medical conditions.
Owner:MCCULLEN NICHOLAS ROSS

Devices and methods for verifying a sample volume

A system for verifying a sample volume includes a sample reservoir and a volumetric verification device. The sample reservoir defines an inner volume and is configured to receive a volume of bodily fluid. The inner volume of the sample reservoir contains an additive. The volumetric verification device includes a first indicator and a second indicator. The volumetric verification device is configured to selectively engage the sample reservoir to (1) place the first indicator in a first position along a length of the sample reservoir such that the first indicator is substantially aligned with a surface and / or meniscus of the additive and (2) place the second indicator in a second position along the length of the sample reservoir such that the second indicator is substantially aligned with a predetermined fill volume when bodily fluid is transferred to the inner volume.
Owner:MAGNOLIA MEDICAL TECHNOLOGIES INC

Method for determining numerical analyte result values

A computer-implemented method for determining a numerical analyte result value corresponding to the concentration of an analyte in a sample of a subject's body fluid applied to a reagent test area includes: (a) determining the numerical analyte result value based on an image of the reagent test area by using an algorithm that takes into account one or more parameters, each parameter adapted to take two or more values; (b) displaying the numerical analyte result value, and / or the corresponding analyte value range, and / or a corresponding message on a display device; and (c) automatically checking for available updated values ​​for one or more parameters on a remote server before performing step (a), and updating the corresponding parameter value taken into account in step (a) for each available updated value.
Owner:F HOFFMANN LA ROCHE & CO AG

Diabetic retinopathy diagnosis and analysis platform based on double-body fluid and method for analyzing biological fluid sample by using diabetic retinopathy diagnosis and analysis platform

The invention discloses a diabetic retinopathy diagnosis and analysis platform based on double body fluids and a method for analyzing a biological fluid sample by using the diabetic retinopathy diagnosis and analysis platform, and relates to the field of biological diagnos.The diabetic retinopathy diagnosis and analysis platform comprises an acquisition and analysis module and a machine learning module, the acquisition and analysis module acquires mass spectrum data of a biological sample through a mass spectrum system for analysis, and the machine learning module analyzes and processes the acquired mass spectrum data of the biological sample, constructs a diabetic retinopathy biomarker panel, and analyzes the diabetic retinopathy biomarker panel to obtain the diabetic retinopathy biomarker. The invention also comprises a method for analyzing a biological fluid sample by using the analysis platform, the biological fluid sample comprises vitreous humor and plasma, and the nanoparticles are used as a matrix of the biological fluid sample for mass spectrum data acquisition. The invention provides a rapid, stable, reliable and high-sensitivity vitreous humor metabonomics detection method and system.
Owner:SHANGHAI JIAOTONG UNIV

Novel funnel type body fluid sample bottle for collecting and storing body fluid sample

ActiveCN223517557ULaboratory glasswaresBody fluid specimenCentrifugation
The utility model provides a novel funnel type body fluid sample bottle for collecting and storing body fluid samples, which comprises a bottle body, the top of the bottle body is in threaded connection with a wide-mouth bottle cap, the bottle body comprises a cylindrical bottle body and a conical bottle body, the cylindrical bottle body is connected with the conical bottle body, the cylindrical bottle body is positioned above the conical bottle body, and the conical bottle body is positioned above the conical bottle body. The bottom of the conical flask body is connected with a return pipeline, an annular protrusion is arranged on the inner side of the lower portion of the cylindrical flask body, a supporting frame is arranged below the cylindrical flask body, and the supporting frame is connected or connected to the outer side of the conical flask body in a sleeved mode. The novel funnel-type body fluid sample bottle for collecting and storing the body fluid sample is simple in structure, the wide-mouth bottle above the bottle body is used for collecting body fluid, the lower portion of the bottle body is funnel-shaped, deposition and centrifugation of visible components are facilitated, the bottom of the conical bottle body is connected with the sample outlet through a return pipeline and is controllable and normally closed, operation is simplified, and the bottle is convenient to use. The opportunity that an operator is in contact with the contents to pollute the contents can be avoided, and the concentration of liquid particle components at the lower part is improved.
Owner:ZHEJIANG GENE SCI CO LTD

Compositions for preserving biological fluid samples

A composition and method for preserving a wide variety of analyte classes, including but not limited to small molecules, peptides, proteins, nucleic acids, carbohydrates, and lipids, ensuring stability and reproducibility of their compartmental concentration over the time course of storage at room temperature, thus enabling cost-efficient tests and logistics for the analysis of these samples.
Owner:THE CHINESE UNIVERSITY OF HONG KONG

A method for monitoring the curative effect of Chinese and Mongolian and western medicines in real time based on biosensing technology

This invention relates to the field of medical data and discloses a method for real-time monitoring of the efficacy of traditional Chinese medicine, Mongolian medicine, and Western medicine based on biosensor technology. This method enables real-time monitoring of drug efficacy and personalized medication guidance. The process includes collecting real-time multimodal biosignals from the user's body surface or minimally invasive body fluid samples to obtain raw sensor signals and acquire sensor array output; extracting real-time pharmacokinetic characteristic signals based on a preset pharmacokinetic model and mapping them to efficacy assessment parameters according to drug type; comparing the efficacy assessment parameters with a preset safe and effective concentration range to generate real-time medication status indicators and dosage adjustment prompts. This invention designs quantitative assessment methods for different types of drugs, enabling real-time comparison to generate efficacy status codes and dosage adjustment suggestions. It comprehensively generates a medication guidance report and transmits it in real-time to the user or clinical monitoring end, allowing for immediate adjustment of the medication regimen and ensuring safe and effective medication.
Owner:AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIV (INNER MONGOLIA AUTONOMOUS REGION CARDIOVASCULAR INST)

Cancer detection assistance method and detection kit

PendingCN121713068ADisease diagnosisBiological testingLiposarcomaTongue Carcinoma
The application finds that SDF4 in a body fluid sample can become a marker for detecting cancer patients with good sensitivity and specificity. By using a reagent for specifically detecting SDF4, gastric cancer, breast cancer, colorectal cancer, pancreatic cancer, esophageal cancer, liver cancer, liposarcoma, bladder cancer, brain tumor, head and neck cancer, gallbladder cancer, ovarian cancer, tongue cancer, or uterine cancer can be detected. The measurement of SDF4 in a body fluid sample is a detection method capable of detecting various cancers by a single test, and can be used for large-scale screening of cancers. In addition, early-stage cancers can be detected with good sensitivity and specificity, so that cancers can be found and treated in an early stage.
Owner:NAT UNIV CORP TOKAI NAT HIGHER EDUCATION & RES SYST

Multi-dimensional tumor marker joint detection device and use method thereof

The invention relates to the technical field of biomedical detection, in particular to a multi-dimensional tumor marker joint detection device and a using method thereof.The device comprises a sample processing module, a sequencing module, a marker extraction module, a feature fusion and detection module and a result output module, and 6 types of markers such as chromosome copy variation, microsatellite instability and the like are extracted respectively. The method comprises the following steps: collecting a body fluid sample to extract cfDNA, directly constructing a library without special treatment, obtaining effective data through whole genome sequencing, synchronously extracting six types of markers through each module of the device, optimizing an algorithm to adapt to low-depth data, inputting an integrated learning model to output a risk score, and finally outputting related information by a result output module. The method does not need special experimental treatment, realizes low-cost and high-accuracy joint detection, and meets the clinical large-scale screening requirements.
Owner:SUZHOU HONGYUAN BIOTECH CO LTD

Body fluid sample collecting device for hydrothorax and ascites and using method thereof

The invention belongs to the technical field of surgical instruments, and provides a body fluid sample collection device for hydrothorax and ascites and a use method thereof. A pretreatment device is arranged between a body fluid bottle and a suction pipeline and comprises a viscosity control part, the viscosity control part is provided with a conical pipe, the inner diameter of the end, close to the suction pipeline, of the conical pipe is smaller than that of the end, away from the suction pipeline, of the conical pipe, and branch pipe openings capable of being opened and closed are formed in the two ends of the conical pipe. The branch pipe openings comprise the first branch pipe opening and the second branch pipe opening, and the first branch pipe opening is closer to the suction pipeline than the second branch pipe opening. The problems that in the hydrothorax and ascites suction process, due to clots such as fibrin of high-viscosity hydrothorax and ascites, a suction pipeline is blocked, and the microscopic examination accuracy is affected are avoided; the problems that before and after the pleural and ascitic fluid needs to be sucked for multiple times and the pleural and ascitic fluid is indwelled and sucked, the pipeline is blocked due to residual clots in the pipeline, and even indwelling and suction instruments need to be replaced are avoided.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY

Method and mobile device for detecting an analyte in a sample of a bodily fluid

A method of detecting an analyte in a body fluid sample using a mobile device having a camera. An image is obtained with the camera of a test field having the body fluid sample applied thereto, causing an optical detection reaction. An algorithm is then performed to determine a potential detection of an optical detection feature and a potential item of intensity information. The potential item of intensity information is weighted with a known item of position probability information. The known item of position probability information is a probability of a potential item of intensity information on the optical detection reaction being a valid item of intensity information. The analyte is detected considering the weighted potential item of intensity information for differentiating a valid from an invalid item of intensity information. A calibration process is then performed in which the known item of position probability information is selected.
Owner:ROCHE DIABETES CARE GMBH

Method for detection of the potential of a body fluid sample to produce extracellular traps

PCT designated stage expiredWO2025012440A1Disease diagnosisBiological testingExtracellularDisease
The invention relates to methods for the detecting or measuring of the potential of cells in a body fluid to produce extracellular trap material which comprises comparing the level of extracellular traps (ETs) measured in a first and second sample of the body fluid, wherein the second sample is incubated for NETosis to proceed for a longer period of time than the first sample. The invention also relates to methods of diagnosing and monitoring disease by investigating the propensity of a body fluid sample obtained from the subject to produce ETs and / or NETs using the methods described.
Owner:BELGIAN VOLITION SRL

Method and kit for detecting Anti-TSH receptor autoantibodies

PCT designated stageWO2025186694A8Antibody mimetics/scaffoldsReceptors for hormonesThyroid stimulating hormone receptorAnticentromere antibodies
The invention relates to a pair of anti-TSH receptor (TSHR) autoantibody-binding fusion proteins consisting of a capture fusion protein and a detection fusion protein, and a method for detecting autoantibodies to the thyroid stimulating hormone receptor (TSHR) in a biological fluid sample, which employs said fusion proteins pair. More specifically, the capture and detection fusion proteins of the pair of the invention comprise an extracellular domain of a human TSHR and a monomeric non-human immunoglobulin Fc domain, or fragment thereof, or a bacterial maltose binding protein (MBP). Also disclosed is a kit for carrying out the method of the invention. In a preferred embodiment, the method of the invention is a sandwich immunoassay.
Owner:DIASORIN ITALIA SPA